1. Construction and Validation of a Prognostic Risk Model for Triple-Negative Breast Cancer Based on Autophagy-Related Genes
   Cheng Yan et al, 2022, Frontiers in Oncology CrossRef
2. Metabolic characterisation of transglutaminase 2 inhibitor effects in breast cancer cell lines
   Mariana Gallo et al, 2023, The FEBS Journal CrossRef
3. Glucose Metabolism in Cancer: The Warburg Effect and Beyond
   Sminu Bose et al, 2021, The Heterogeneity of Cancer Metabolism CrossRef
4. Case Report of a Breast Mass with Three Types of Malignant Tumors—Squamous Cell Carcinoma, Invasive Ductal Carcinoma, and Breast Sarcoma
   Chao Li et al, 2021, OncoTargets and Therapy CrossRef
5. Immature natural killer cells promote progression of triple-negative breast cancer
   Gatha Thacker et al, 2023, Science Translational Medicine CrossRef
6. Identification and panoramic analysis of drug response-related genes in triple negative breast cancer using as an example NVP-BEZ235
   Jia Feng et al, 2023, Scientific Reports CrossRef
7. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival
   Dai Zhang et al, 2021, Frontiers in Oncology CrossRef
8. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
   Nuria Gómez-Cebrián et al, 2021, Cancers CrossRef
9. Facts and Perspectives: Implications of tumor glycolysis on immunotherapy response in triple negative breast cancer
   Ashley Schreier et al, 2023, Frontiers in Oncology CrossRef
10. Development of a Gene Risk Signature for Patients of Pancreatic Cancer
    Tao Liu et al, 2022, Journal of Healthcare Engineering CrossRef
11. Gene Expression Signatures of the Tumor Microenvironment: Relation to Tumor Phenotypes and Progress in Breast Cancer
    Elisabeth Wik et al, 2022, Biomarkers of the Tumor Microenvironment CrossRef